News

OVPR is accepting applications for OVPR COVID-19 Rapid Response Grants, a program that aims to catalyze and energize small-scale research projects designed to address and mitigate the risk associated with the coronavirus pandemic, including cascading impacts in communities.

The University of Minnesota Office of Budget and Finance has reached an agreement with the Department of Health and Human Services (DHHS) on the FY21 fringe benefit rates.

UMN Technology Commercialization's Venture Center was among the winners of this year's Inno on Fire awards.

For the last 10 years, spatial researchers at the University of Minnesota Duluth have been collaborating with local governments to help them prepare for the worst that nature might throw at them.

VPR Cramer and Technology Commercialization staff visited the Moriarity lab, which is developing novel cellular therapeutics for genetherapy and cancer immunotherapy.

Two UMN startups, Anatomi and Stim Sherpa, are among the five companies selected to participate in the gBETA Medtech accelerator.

On January 24, 2020, Vice President for Research Chris Cramer overviewed the University of Minnesota’s work in research, teaching, engagement, and operations before a group of lawmakers interested in climate change issues.   

Twin Cities Business recently rounded up 20 of the innovators and innovations leading Minnesota into the 2020s. This list includes UMN startups Anatomi Corp. and Calyxt Inc.

On January 14, Technology Commercialization hosted its first ever waffle breakfast for innovators who are new to the University of Minnesota in the past three years.

MIN-Corps is hosting a series of seminars and coaching that teach innovators how to translate research to products with real-world impact. The events are free to UMN Grad Students, Postdocs, Fellows, Research Scientists & Faculty.